SERIES 3 COMMON STOCK PURCHASE WARRANT JAGUAR HEALTH, Inc.Jaguar Health, Inc. • May 22nd, 2020 • Pharmaceutical preparations • New York
THIS SERIES 3 COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _______________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the earlier of (1) the date Stockholder Approval (as defined in the Inducement Offer Letter) is obtained or (2) November __, 2020 (the “Initial Exercise Date”) and on or prior to the Termination Date (as defined in Section 1 below) but not thereafter, to subscribe for and purchase from Jaguar Health, Inc., a Delaware corporation (the “Company”), up to _________________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock (“Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
